In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...

Indian pharmaceutical company, Zydus Lifesciences, is planning to launch a semaglutide injection for the treatment of obesity and diabetes. The company is launching generic versions of semaglutide ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

The Food and Drug Administration (FDA) approved a generic version of the abortion pill mifepristone in October, making chemical abortion more affordable and accessible to pregnant women who wish to ...

Adderall is a central nervous system stimulant prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines. Dr. Reddy’s, an Indian generic ...

The Food and Drug Administration (FDA) approved a new generic form of the abortion pill mifepristone this week, drawing upset from conservative voices. On Tuesday, the FDA sent a letter to Evita ...

Marion Bradley, 57, filling a prescription for one of her customers . She is the lead pharmacist and co-owner of Beacon Falls Pharmacy. Credit: Carl Jordan Castro / C-HIT.org India supplies nearly ...

With over 400 million chronic patients, India is one of the world’s largest medicine markets. But while most e-pharmacies chase speed, affordability remains the real challenge. Truemeds took a ...